MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

J&J

  • T-Mobile to Buy Most of US Cellular for $4.4 Billion; Court to Hear TikTok Ban Challenges in Sept. | Business Matters Full Broadcast (May 28)
    T-Mobile to Buy Most of US Cellular for $4.4 Billion; Court to Hear TikTok Ban Challenges in Sept. | Business Matters Full Broadcast (May 28)
    The Nasdaq crossed 17,000 for the first time ever on Tuesday, boosted by gains in Nvidia, while the S&P 500 closed barely higher and the Dow ended lower as Treasury ...
    May 28, 2024BY Don Ma
  • J&J Tops 4th-Quarter Earnings Forecasts as Profit, Revenue Slip
    J&J Tops 4th-Quarter Earnings Forecasts as Profit, Revenue Slip
    Johnson & Johnson beat earnings expectations in the final quarter of 2022 even as a strong dollar and ...
    January 24, 2023BY The Associated Press
  • J&J’s Cancer Drug Sales Help Weather Hit From Stronger Dollar
    J&J’s Cancer Drug Sales Help Weather Hit From Stronger Dollar
    Johnson & Johnson on Tuesday reported quarterly results that beat analysts' estimates on strong demand for cancer drug ...
    July 21, 2022BY Reuters
  • Contract Manufacturer Emergent Says J&J Breached Vaccine Contract
    Contract Manufacturer Emergent Says J&J Breached Vaccine Contract
    Contract manufacturer Emergent BioSolutions Inc. said on Monday U.S. drugmaker Johnson & Johnson had breached an agreement by ...
    June 7, 2022BY Reuters
  • J&J Sues to Block Sales of ‘Dangerous’ Counterfeit HIV Drugs
    J&J Sues to Block Sales of ‘Dangerous’ Counterfeit HIV Drugs
    Johnson & Johnson has filed a lawsuit against drug distributors and a pharmacy seeking to stop the sale ...
    April 28, 2022BY Reuters
  • J&J Suspends Sales Forecast for COVID Vaccine Citing Uncertainty in Demand, Global Supply Surplus
    J&J Suspends Sales Forecast for COVID Vaccine Citing Uncertainty in Demand, Global Supply Surplus
    Johnson & Johnson suspended sales forecasts for its COVID-19 vaccine on April 19, citing a global supply surplus and ...
    April 20, 2022BY Katabella Roberts
  • EU Regulator Backs Giving J&J Booster Shot to Adults 2 Months After Initial Dose
    EU Regulator Backs Giving J&J Booster Shot to Adults 2 Months After Initial Dose
    The European Union’s drug regulator on Dec. 15 concluded that a Johnson & Johnson (J&J) COVID-19 booster dose ...
    December 15, 2021BY Lorenz Duchamps
  • Wall Street Powers Higher on J&J, Big Tech Boost
    Wall Street Powers Higher on J&J, Big Tech Boost
    U.S. stock indexes rose on Friday, as Johnson & Johnson and big technology and communication stocks led gains ...
    November 12, 2021BY Reuters
  • US Judge Halts Johnson & Johnson Talc Litigation for 60 Days
    US Judge Halts Johnson & Johnson Talc Litigation for 60 Days
    CHARLOTTE, N.C.—A U.S. bankruptcy judge on Wednesday put a 60-day halt on tens of thousands of legal claims ...
    November 11, 2021BY Reuters
  • Oklahoma Court Overturns $465 Million Opioid Judgment Against J&J
    Oklahoma Court Overturns $465 Million Opioid Judgment Against J&J
    The Oklahoma Supreme Court on Tuesday overturned a $465 million judgment against Johnson & Johnson in a lawsuit ...
    November 10, 2021BY Reuters
  • J&J Settles Most Risperdal Lawsuits, With $800 Million in Expenses
    J&J Settles Most Risperdal Lawsuits, With $800 Million in Expenses
    Johnson & Johnson said it has settled most of the lawsuits it faced by thousands of men who ...
    October 30, 2021BY Reuters
  • J&J Says COVID-19 Booster Dose Increases Antibody Levels ‘Nine-Fold’
    J&J Says COVID-19 Booster Dose Increases Antibody Levels ‘Nine-Fold’
    Johnson & Johnson's COVID-19 booster shots are able to generate high levels of antibodies and increase people's immunity ...
    August 25, 2021BY Lorenz Duchamps
  • J&J CEO Gorsky to Step Down, Company Veteran to Lead in 2022
    J&J CEO Gorsky to Step Down, Company Veteran to Lead in 2022
    Johnson & Johnson will replace Chairman and CEO Alex Gorsky with another veteran company executive starting next year. ...
    August 20, 2021BY The Associated Press
  • J&J Recalls Sunscreens After Carcinogen Found in Some Sprays
    J&J Recalls Sunscreens After Carcinogen Found in Some Sprays
    Johnson & Johnson is voluntarily recalling five Neutrogena and Aveeno brand aerosol sunscreen products after detecting a cancer-causing ...
    July 15, 2021BY Reuters
  • Germany Demands J&J Make Up Likely Millions of Lost COVID-19 Vaccine Shots for July
    Germany Demands J&J Make Up Likely Millions of Lost COVID-19 Vaccine Shots for July
    Germany's health ministry has demanded that pharmaceutical giant Johnson & Johnson provide more doses of its single-shot COVID-19 ...
    June 13, 2021BY Jack Phillips
  • Johnson & Johnson COVID-19 Vaccine Use Should Resume: CDC Advisers
    Johnson & Johnson COVID-19 Vaccine Use Should Resume: CDC Advisers
    Advisers to the Centers for Disease Control and Prevention (CDC) on Friday said the Johnson & Johnson (J&J) CCP ...
    April 23, 2021BY Jack Phillips
  • J&J to Cooperate in Study of Rare Blood Clots Linked to CCP Virus Vaccine
    J&J to Cooperate in Study of Rare Blood Clots Linked to CCP Virus Vaccine
    Johnson & Johnson has agreed to work with a German scientist studying rare blood clots linked to its ...
    April 20, 2021BY Ivan Pentchoukov
  • 7th Case of Rare, Severe Blood Clot Linked to J&J Vaccine
    7th Case of Rare, Severe Blood Clot Linked to J&J Vaccine
    The Centers for Disease Control and Prevention (CDC) said on April 14 that it learned of a seventh ...
    April 15, 2021BY Jack Phillips
  • CDC Vaccine Advisory Committee Says J&J COVID-19 Vaccine to Remain on Pause
    CDC Vaccine Advisory Committee Says J&J COVID-19 Vaccine to Remain on Pause
    The Johnson & Johnson (J&J) COVID-19 vaccine will remain on pause after an advisory committee to the Centers ...
    April 15, 2021BY Meiling Lee
  • CDC Investigates Death of Woman Who Took J&J Vaccine
    CDC Investigates Death of Woman Who Took J&J Vaccine
    The Centers for Disease Control and Prevention (CDC) on Tuesday confirmed that it is investigating the death of a woman who ...
    April 14, 2021BY Mimi Nguyen Ly
  • Fauci Says J&J Vaccine Pause Will Only Last ‘Days to Weeks,’ Rather Than Months
    Fauci Says J&J Vaccine Pause Will Only Last ‘Days to Weeks,’ Rather Than Months
    Dr. Anthony Fauci said on Tuesday that the pause on the Johnson & Johnson vaccine would be temporary and ...
    April 13, 2021BY Bowen Xiao
  • Pentagon Halts Usage of COVID-19 Vaccine on Military: Official
    Pentagon Halts Usage of COVID-19 Vaccine on Military: Official
    The Department of Defense (DOD) said it is halting the administration of the Johnson & Johnson vaccine to ...
    April 13, 2021BY Jack Phillips
  • J&J Takes Over Baltimore Vaccine Plant Where 15 Million Doses Were Contaminated
    J&J Takes Over Baltimore Vaccine Plant Where 15 Million Doses Were Contaminated
    Pharmaceutical giant Johnson & Johnson said on April 3 that it's taking charge of a Baltimore manufacturing plant ...
    April 4, 2021BY Bill Pan
  • Johnson & Johnson Asks for Emergency Use Authorization of Its COVID-19 Vaccine
    Johnson & Johnson Asks for Emergency Use Authorization of Its COVID-19 Vaccine
    Johnson & Johnson asked U.S. regulators Thursday to clear the world’s first single-dose COVID-19 vaccine, an easier-to-use option ...
    February 5, 2021BY The Associated Press
  • AstraZeneca Resumes COVID-19 Vaccine Trial in US, J&J to Follow
    AstraZeneca Resumes COVID-19 Vaccine Trial in US, J&J to Follow
    AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & ...
    October 23, 2020BY Reuters
  • Johnson & Johnson Announces Start of Phase 3 Trials for CCP Virus Vaccine
    Johnson & Johnson Announces Start of Phase 3 Trials for CCP Virus Vaccine
    U.S. company Johnson & Johnson on Sept. 23 announced it has reached phase three clinical trials for its ...
    September 24, 2020BY Mimi Nguyen Ly
  • J&J Loses Bid to Overturn Baby Powder Verdict, but Damages Cut to $2.12 Billion
    J&J Loses Bid to Overturn Baby Powder Verdict, but Damages Cut to $2.12 Billion
    A Missouri appeals court on June 23 rejected Johnson & Johnson's bid to throw out a jury verdict ...
    June 23, 2020BY Reuters
TOP NEWS
  • Here’s Who Won Key House Primaries in Arizona
    NEW By Nathan Worcester
    Here’s Who Won Key House Primaries in Arizona
  • FDA Investigates New Cyclospora Outbreak as Cases on Rise Across Midwest
    2hr By Kimberly Hayek
    FDA Investigates New Cyclospora Outbreak as Cases on Rise Across Midwest
  • Trump Denounces Communism, Touts Trump Accounts for Children in Georgia Speech
    4hr By Travis Gillmore
    Trump Denounces Communism, Touts Trump Accounts for Children in Georgia Speech
  • 124 Swiss Lawmakers Condemn Beijing’s Transnational Repression of Falun Gong
    4hr By Arthur Zhang
    124 Swiss Lawmakers Condemn Beijing’s Transnational Repression of Falun Gong
  • Live From Capitol Hill: ‘Unbroken’ Panel Discussion on Artistic Freedom
    4hr By Epoch Video
    Live From Capitol Hill: ‘Unbroken’ Panel Discussion on Artistic Freedom
  • The New Cholesterol Pill Isn’t for Everyone. Here’s How to Tell.
    5hr By Sheramy Tsai
    The New Cholesterol Pill Isn’t for Everyone. Here’s How to Tell.
  • Senate Panel Advances Bill to Make Hospitals Compete on Price
    5hr By Lawrence Wilson
    Senate Panel Advances Bill to Make Hospitals Compete on Price
  • House Adopts Budget Blueprint for $95 Billion Reconciliation Package
    6hr By Jackson Richman
    House Adopts Budget Blueprint for $95 Billion Reconciliation Package
  • House Passes Congressional Stock Trading Ban
    6hr By Jackson Richman and Nathan Worcester
    House Passes Congressional Stock Trading Ban
  • US Signs Nuclear Cooperation Deal With Saudi Arabia
    6hr By Emel Akan
    US Signs Nuclear Cooperation Deal With Saudi Arabia
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top